NeuroRx is a clinical stage, small molecule pharmaceutical company developing novel therapeutics for the treatment of Acute Suicidal Ideation/Behavior (ASIB). Our first drug is NRX-101, and is being developed for ASIB in Bipolar Depression


The NeuroRx team reaches beyond boundaries, thinks beyond standards and explores beyond borders. We have the courage to try what others have not yet tried.

If you believe you can contribute to our development of NRX-101 (Cyclurad™) for patients battling acute suicidal crisis associated with bipolar disorder, we’d be glad to hear from you at


© 2016 NeuroRx, Inc.

*This drug is investigational and not approved by the US FDA